Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

The paper's citation list
No.The paper's citation list
1Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients. 2021;11: doi: 10.1038/s41598-021-82068-9
2Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC. 2021;13:2139 doi: 10.3390/cancers13092139
3Design, Synthesis, Molecular Docking, and Biological Studies of New Heterocyclic Compounds Derived from β-Diketones as Novel EGFR and Pim-1 Inhibitors Endowed with Antitumor Activity. 2022;22:2558 doi: 10.2174/1871520622666220112104320
4A serine/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy. 2020;255:117866 doi: 10.1016/j.lfs.2020.117866
5Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells. 2023;79:129066 doi: 10.1016/j.bmcl.2022.129066
6PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer. 2020;5: doi: 10.1038/s41392-020-0109-y
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties